Corvus Pharmaceuticals, Inc. (CRVS)

Corvus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Quarter	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Cash & Equivalents	40.1	4.58	2.87	14.69	5	8.74	4.68	14.84	7.46	12.62	20.11	7.66	9.65	13.16	24.59	28.48	31.46	63.46	72.3	58.92
Short-Term Investments	196.61	52.17	62.82	59.72	39.21	43.22	36.97	32.41	14.67	14.53	12.06	29.36	24.81	29.14	25.03	28.25	31.48	5.99	4.03	7.55
Cash & Short-Term Investments	236.71	56.75	65.69	74.41	44.21	51.96	41.65	47.25	22.13	27.15	32.17	37.02	34.47	42.3	49.62	56.72	62.94	69.45	76.33	66.46
Cash Growth (YoY)	435.41%	9.21%	57.71%	57.49%	99.80%	91.40%	29.48%	27.63%	-35.80%	-35.82%	-35.17%	-34.74%	-45.24%	-39.09%	-35.00%	-14.65%	-7.39%	56.92%	48.61%	12.15%
Accounts Receivable	0.04	0.04	0.03	0.09	0.08	0.08	0.07	0.04	0.03	0.03	0.01	-	0.43	0.59	0.5	0.37	0.37	0.51	0.28	-
Other Current Assets	3.19	1.43	1.22	1.29	1.2	2.37	1.2	0.98	0.7	0.78	0.92	0.89	0.66	0.77	1.15	1.79	1.05	1.35	2.15	2.66
Total Current Assets	239.95	58.21	66.94	75.78	45.49	54.41	42.92	48.26	22.85	27.96	33.09	37.91	35.55	43.66	51.27	58.89	64.37	71.31	78.76	69.12
Net Property, Plant & Equipment	1.03	1.06	1.15	1.26	1.26	1.33	0.46	0.77	1.08	1.39	1.69	1.99	2.28	2.57	2.91	3.24	3.32	3.64	3.96	1.91
Long-Term Investments	10.5	10.99	11.53	11.79	12.06	12.54	15.19	15.4	16.07	16.12	17.07	18.02	20.23	21.88	25.91	30.18	33.37	34.27	36.33	38.05
Other Long-Term Assets	1.72	0.86	0.85	0.63	0.63	0.63	0.25	0.13	0.09	0.09	0.09	0.13	0.13	0.13	0.25	0.24	0.24	0.24	0.28	0.32
Total Assets	253.2	71.12	80.47	89.46	59.44	68.91	58.82	64.56	40.08	45.55	51.94	58.04	58.2	68.24	80.35	92.54	101.29	109.46	119.32	109.39

Liabilities

Fiscal Quarter	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Accounts Payable	4.7	2.49	1.97	3.14	1.31	2.58	1.87	1.21	1.61	1.53	1.4	2.1	1.41	1.98	4.23	2.65	2.19	1.57	2.33	2.87
Accrued Expenses	6.99	6.49	5.72	5.01	3.87	3.73	4.22	4.3	4.07	3.97	4.56	4.46	5.62	7.55	8.57	6.37	5.99	7.08	7.96	8.34
Current Portion of Leases	0.43	0.4	0.38	0.36	0.32	0.19	0.35	0.7	1.04	1.37	1.34	1.3	1.26	1.23	1.18	1.14	1.09	1.05	1.02	1.15
Other Current Liabilities	-	-	-	-	3.78	28.91	39.96	7.12	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	12.11	9.38	8.07	8.51	9.28	35.4	46.41	13.34	6.72	6.87	7.3	7.86	8.29	10.75	13.98	10.16	9.27	9.69	11.31	12.36
Long-Term Leases	0.41	0.53	0.63	0.73	0.83	0.94	-	-	-	-	0.35	0.7	1.04	1.37	1.69	2	2.3	2.6	2.87	0.63
Total Long-Term Liabilities	0.41	0.53	0.63	0.73	0.83	0.94	-	-	-	-	0.35	0.7	1.04	1.37	1.69	2	2.3	2.6	2.87	0.63
Total Liabilities	12.52	9.91	8.71	9.23	10.11	36.34	46.41	13.34	6.72	6.87	7.65	8.56	9.33	12.13	15.67	12.16	11.57	12.29	14.18	12.99

Shareholders' Equity

Fiscal Quarter	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-in Capital	667.78	474.39	472.79	471.18	432.39	430.86	398.04	397.26	375.05	374.36	373.79	372.91	364.86	364.36	363.74	363.08	362.41	361.67	360.91	341.48
Accumulated Other Comprehensive Income	-1.13	-0.9	-1.06	-1.15	-1.25	-1.29	-0.74	-1.36	-1.28	-0.97	-1.44	-1.37	-0.43	-0.56	-1.19	0.34	1.99	1.87	1.38	1.39
Retained Earnings	-425.99	-412.29	-399.97	-389.82	-381.82	-397.01	-384.9	-344.68	-340.42	-334.72	-328.06	-322.06	-315.56	-307.69	-297.87	-283.04	-274.68	-266.38	-257.15	-246.47
Shareholders' Equity	240.68	61.21	71.77	80.23	49.33	32.57	12.41	51.23	33.36	38.68	44.29	49.48	48.87	56.12	64.68	80.39	89.72	97.16	105.15	96.4
Total Liabilities & Equity	253.2	71.12	80.47	89.46	59.44	68.91	58.82	64.56	40.08	45.55	51.94	58.04	58.2	68.24	80.35	92.54	101.29	109.46	119.32	109.39

Additional Metrics

Fiscal Quarter	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Total Debt	0.83	0.94	1.01	1.08	1.15	1.12	0.35	0.7	1.04	1.37	1.69	2	2.3	2.6	2.87	3.13	3.39	3.65	3.89	1.78
Net Cash (Debt)	235.88	55.81	64.68	73.32	43.06	50.84	41.3	46.55	21.09	25.78	30.48	35.02	32.16	39.7	46.75	53.59	59.55	65.8	72.44	64.68
Net Cash Growth (YoY)	447.81%	9.78%	56.62%	57.53%	104.19%	97.25%	35.50%	32.92%	-34.44%	-35.08%	-34.80%	-34.65%	-45.99%	-39.67%	-35.47%	-17.14%	-9.66%	56.87%	48.38%	14.47%
Net Cash Per Share	2.62	0.67	0.78	0.94	0.57	0.74	0.62	0.78	0.43	0.53	0.62	0.74	0.69	0.85	1.00	1.15	1.28	1.41	1.65	1.53
Book Value	240.68	61.21	71.77	80.23	49.33	32.57	12.41	51.23	33.36	38.68	44.29	49.48	48.87	56.12	64.68	80.39	89.72	97.16	105.15	96.4
Book Value Per Share	2.67	0.74	0.87	1.03	0.66	0.48	0.19	0.86	0.68	0.79	0.90	1.04	1.05	1.21	1.39	1.73	1.93	2.09	2.39	2.28
Tangible Book Value	240.68	61.21	71.77	80.23	49.33	32.57	12.41	51.23	33.36	38.68	44.29	49.48	48.87	56.12	64.68	80.39	89.72	97.16	105.15	96.4
Tangible Book Value Per Share	2.67	0.74	0.87	1.03	0.66	0.48	0.19	0.86	0.68	0.79	0.90	1.04	1.05	1.21	1.39	1.73	1.93	2.09	2.39	2.28

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 7, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 4, 2026

Data Sources Report a data error